Paper

Paper

Changelog Terms Privacy Issues Docs Support Foundation About

Short-term Clinical Effects of Tolvaptan, an Oral Vasopre... | ResearchHub

Paper

Paper

Supporters

Support the authors with ResearchCoin

Journal

Topics

Internal Medicine

Pulmonary And Respiratory Medicine

DOI

10.1001/jama.297.12.1332

Changelog Terms Privacy Issues Docs Support Foundation About

Short-term Clinical Effects of Tolvaptan, an Oral Vasopressin Antagonist, in Patients Hospitalized for Heart Failure<SUBTITLE>The EVEREST Clinical Status Trials</SUBTITLE>

0

Authors

Mihai Gheorghiade

Mihai Gheorghiade•Mihai Gheorghiade•Cesare Orlandi

Published

March 25, 2007

Abstract

Outcome Study With Tolvaptan (EVEREST) Investigators HEART FAILURE (HF) IS A MAjor international public health problem presenting significant medical and economic challenges.][5][6][7][8] Congestion characterized by dyspnea, edema, rales, jugular venous dis-See also pp

Supporters

Support the authors with ResearchCoin

Journal

Topics

Internal Medicine

Pulmonary And Respiratory Medicine

DOI

10.1001/jama.297.12.1332